Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H+-translocating pyrophosphatase (H+-PPase), also known as vacuolar H+-translocating pyrophosphatase, is a membrane-bound enzyme that couples the hydrolysis of inorganic pyrophosphate (PPi) to the active transport of protons across biological membranes [1, 5]. It is a unique type of proton pump, distinct from F-, P-, and V-type ATPases, and typically functions as a homodimer composed of a single 70-80 kDa polypeptide [5, 13]. The enzyme is primarily found in the vacuolar membranes of plants and the plasma or organellar membranes of various protozoa, bacteria, and archaea [1, 6]. In plants, it plays a dual role in acidifying the vacuole and maintaining low cytosolic PPi levels to prevent the inhibition of biosynthetic reactions [5, 15]. In parasitic protozoa like Plasmodium falciparum and Leishmania, H+-PPase is essential for maintaining intracellular pH and ion homeostasis [4]. Because H+-PPase is entirely absent in humans and fungi, it represents a promising target for the development of selective antiprotozoal drugs [4, 5]. Compounds such as bisphosphonates and their analogs have been shown to inhibit H+-PPase activity, effectively disrupting the bioenergetics of the parasite [4, 13]. Targeting this enzyme offers a strategy to combat drug-resistant strains of malaria and other neglected tropical diseases [4].
Inhibition of pyrophosphate hydrolysis and proton translocation, leading to disruption of intracellular pH homeostasis and accumulation of toxic levels of inorganic pyrophosphate.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H+-translocating pyrophosphatase (H+-PPase).